Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.95M Buy
46,341
+66
+0.1% +$7.72K 0.74% 27
2026
Q1
$5.47M Buy
46,275
+856
+2% +$98.8K 0.52% 41
2025
Q4
$4.78M Buy
45,419
+326
+0.7% +$30.6K 0.73% 29
2025
Q3
$3.78M Buy
45,093
+4,817
+12% +$397K 0.6% 40
2025
Q2
$3.19M Buy
+40,276
New +$3.2M 0.98% 35

Other funds holding MRK

HORAN Wealth's MRK Position: Q2 2026 in Review

HORAN Wealth increased its Merck (MRK) stake by 0.14% in Q2 2026, buying an estimated $7.72K and bringing the position to 46,341 shares worth $5.95M. The position accounts for 0.74% of the portfolio, ranked #27.

HORAN Wealth first reported a position in MRK in Q2 2025 and has held it in 5 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • HORAN Wealth held 46,341 shares of Merck worth $5.95M as of Q2 2026.
  • HORAN Wealth bought 66 Merck shares in Q2 2026, an estimated $7.72K.
  • Merck made up 0.74% of HORAN Wealth's portfolio in Q2 2026, its #27 holding.
  • HORAN Wealth first reported a position in Merck in Q2 2025 and has held it in 5 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on HORAN Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.